Rick Simpson Oil (RSO) in Cleveland County, Arkansas: The Complete Guide by OilWell Cannabis

If you’re reading this from Cleveland County — whether you’re in Rison, Kingsland, New Edinburg, or out on the land between Moro Bay and Millwood Lake — you’ve probably heard the name “Rick Simpson Oil” floating through conversations at the feed store, in waiting rooms at the Cleveland County Medical Center, or among neighbors struggling with pain that just won’t quit. Maybe you’re dealing with chronic pain from years of timber work, caring for a loved one facing cancer treatment in Little Rock, or searching for alternatives after watching the opioid crisis devastate families across southeastern Arkansas. Whatever brought you here, we want you to know three things right up front:

First, we respect the hell out of what Rick Simpson started. He wasn’t a doctor or a scientist — he was a regular working guy in Nova Scotia who saw the medical system fail him and decided to do something about it. That story resonates here in Cleveland County, where the nearest oncologist might be a two-hour drive away and where too many people have been told “there’s nothing more we can do” by doctors who won’t even discuss cannabis as an option.

Second, traditional RSO had serious problems. The old methods used toxic solvents like naphtha, produced inconsistent batches, and delivered massive doses of THC that left people too impaired to function. Folks in Cleveland County who need to work their land, drive to Pine Bluff for supplies, or simply stay clear-headed for their families can’t afford that approach.

Third, our formulas are different — deliberately, thoughtfully different. We publish every single ingredient and milligram amount publicly, right here in this document, because we believe the people of Cleveland County deserve the same transparency whether they buy from us or make their own. This is education first, always.

ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL

Who is Rick Simpson

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor, scientist, or medical professional. He was a power engineer and maintenance worker — a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from a scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and a constellation of post-concussion symptoms that conventional medicine could not adequately resolve. According to Simpson, the medications he was prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused .

Sound familiar, Cleveland County? We hear this story weekly from folks in Rison who’ve been prescribed gabapentin that left them foggy, or from timber workers outside Kingsland who’ve been cycled through pain pills that don’t touch their nerve damage. The frustration of being told “no” by a doctor when you’re desperate for relief is universal.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment in Simpson’s story came in 2003. He reported that three bumps on his arm were diagnosed by his doctor as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed .

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement.

The crusade — spreading the oil

After his 2003 experience, Simpson committed himself fully to producing and distributing concentrated cannabis oil. Operating out of his property in Maccan, Nova Scotia, he began making the oil in large quantities and giving it away for free to cancer patients and others in his community. He charged nothing. By his own account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and others .

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. Within cannabis communities, it was foundational — for many people, Run From The Cure was their introduction to the concept of concentrated cannabis oil as medicine .

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005 and 2009, seizing plants and equipment. He was charged with cannabis cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe .

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, a book detailing his personal experience, his oil-making process, and his broader philosophical views on cannabis, medicine, and institutional suppression .

Throughout his public career, Simpson’s position remained consistent and uncompromising: he maintained that cannabis oil could cure cancer and many other diseases, and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge .

Important context: Simpson’s conspiratorial framing is noted here without endorsement or dismissal. It reflects a worldview shared by many in the early cannabis movement and is relevant to understanding why RSO became culturally significant.

The traditional RSO protocol — Simpson’s 60-gram, 90-day regimen

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver a total of 60 grams of concentrated cannabis oil over roughly 90 days. He described this as a cancer treatment protocol, though he also recommended it for numerous other conditions .

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over approximately 90 days. Simpson considered this the minimum amount necessary for a serious cancer treatment course.

Titration schedule

• Week 1: Begin with a dose approximately the size of half a grain of dry rice — roughly 10 to 15 milligrams of oil — taken three times per day. Total daily intake: approximately 30 to 45 milligrams.
• Weeks 2 through 5: Double the dose approximately every four days. By the end of this escalation period, the target was to reach approximately 1 gram (1,000 milligrams) of oil per day, divided into three roughly equal doses.
• Weeks 5 through 12: Maintain the full dose of approximately 1 gram per day, divided into three doses of roughly 333 milligrams each, and continue until the full 60 grams have been consumed.

Administration methods

• Primary method — oral: Simpson recommended placing the dose directly under the tongue (sublingual) or swallowing it.
• Secondary method — topical: For skin cancers and external lesions, Simpson recommended applying the oil directly to the affected area, covering it with a bandage, and changing the bandage every three to four days.
• Not recommended as primary — inhalation: Simpson did not recommend smoking or vaporizing the oil as a primary treatment method.

Important context for evaluating this protocol

This protocol was designed by one person based on his personal experience. It was not developed through clinical trials, dose-finding studies, or formal research. Several critical points apply:

• No controlled trial validation. There are no published randomized controlled trials evaluating this specific 60-gram/90-day protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content varied widely.
• Very high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil per day. Assuming 60 to 90 percent THC, this translates to approximately 600 to 900 milligrams of delta-9 THC per day — a dose far exceeding anything studied in controlled clinical settings. The FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20 milligrams per day.
• Real risks at these doses. Consuming 600 to 900 milligrams of THC daily carries serious risks including severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].
• Oncology context. Patients with active cancer are often medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment — potentially in place of proven therapies — introduces harm that extends beyond the oil itself.

For Cleveland County residents considering any cannabinoid approach, this protocol highlights why modern, standardized formulations with dramatically lower THC exposure represent a fundamentally different risk-benefit profile.

What is traditional Rick Simpson Oil — the product

Traditional RSO refers to the specific type of concentrated cannabis oil that Simpson made and advocated for. It was defined not by lab specifications but by his method and materials .

Source material

Simpson used high-THC, indica-dominant cannabis strains. There was no strain standardization — the starting material varied by availability and growing season.

Extraction solvent

Simpson originally used naphtha — a petroleum-based solvent commercially available as lighter fluid. He later also endorsed 99 percent isopropyl alcohol. Neither is a food-grade solvent, which is a significant safety issue.

Extraction process

The process involved: placing cannabis in a bucket, covering with solvent, agitating, filtering through cheesecloth, evaporating solvent in a rice cooker at temperatures sufficient to decarboxylate THCa into THC, and transferring the thick, dark oil into oral syringes.

Appearance and physical characteristics

Traditional RSO was an extremely dark — nearly black — thick, viscous, tar-like oil with a strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile

• Primarily decarboxylated delta-9 THC. The heat converted essentially all THCa into delta-9 THC.
• Naturally occurring minor cannabinoids. Whatever CBD, CBN, CBC, CBG the source strain contained were present at natural ratios, but these were not controlled, measured, or targeted.
• Estimated THC content. Depending on starting material, traditional RSO likely ranged from approximately 60 to 90 percent total THC by weight, though this was never lab-verified.

Terpene content

Minimal to none. The combination of solvent extraction and high-heat evaporation meant traditional RSO was effectively stripped of its terpene content.

Standardization and testing

None. Every batch was different because it depended entirely on the starting plant material, growing conditions, solvent purity, extraction technique, and the individual maker’s process. There was no Certificate of Analysis, no cannabinoid quantification, and no contaminant screening.

Residual solvent risk

Naphtha and isopropyl alcohol are not food-grade solvents. Naphtha is a complex mixture of petroleum hydrocarbons that may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves potentially harmful residues in the finished oil. Modern extraction methods use food-grade ethanol or supercritical CO₂ specifically to address this problem.

Simpson’s claims vs. the evidence record

Rick Simpson made expansive therapeutic claims about his oil. He stated that RSO could cure cancer and was effective against diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, multiple sclerosis, and numerous other conditions .

What Simpson was not

Simpson was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, pharmacology, or clinical research methodology. He never designed, conducted, funded, or published a clinical trial. He never submitted his results to peer review. His entire evidence base consisted of personal experience, self-reported patient outcomes, and testimonials gathered informally.

What the preclinical literature shows

The preclinical cannabinoid-cancer literature does exist and is scientifically interesting:

• In vitro studies have demonstrated that THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines .
• Animal model studies have shown some tumor-growth inhibition in mice and rats treated with cannabinoids .

What the preclinical literature does not show

• These findings have not translated into proven human cancer cures. The gap between in vitro or animal results and human clinical outcomes is vast.
• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.

Institutional positions

• The U.S. National Cancer Institute (NCI) acknowledges cannabinoids have been studied for potential anticancer effects but does not endorse cannabis or cannabis oil as a cancer treatment .
• The U.S. Food and Drug Administration (FDA) has not approved any cannabis plant product for cancer treatment. The only FDA-approved cannabinoid products are for specific other indications [1].
• Health Canada has never approved RSO or cannabis oil as a cancer cure.
• NCCIH states the strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea, and HIV/AIDS appetite issues — not cancer cure [1].

What Simpson got right

Simpson drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. He helped create the conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated

The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it is not supported now. Encouraging patients — particularly cancer patients — to rely on RSO as a primary treatment in place of proven oncologic therapies carries genuine harm potential.

If you or someone you love in Cleveland County is facing cancer, please consult with oncologists at UAMS in Little Rock or seek care through the Arkansas Cancer Coalition. RSO education should complement medical care, not replace it.

The legacy of Rick Simpson and the evolution of modern RSO

The term RSO is now used broadly across the legal cannabis industry. Many products labeled as RSO bear little resemblance to what Simpson originally made. Simpson himself has been critical of commercial products that use the RSO name while departing significantly from his original method and philosophy .

What is not in dispute is that modern RSO has evolved substantially from its origins. OilWell’s formulas are informed by the RSO tradition but depart from it in deliberate, evidence-motivated ways that solve the problems that limited Rick Simpson’s original vision.

Traditional RSO vs. modern formulated RSO

Dimension	Traditional RSO	OilWell formulated RSO
Source material	Single high-THC indica strain, uncontrolled	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol (toxic)	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled, 60-90% estimated	7 defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined 7-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets (553mg/mL)
Lab testing	Not available or performed	Full panel testing (potency, terpenes, pesticides, heavy metals, residual solvents, microbial)
Residual solvents	Significant risk with naphtha	Controlled and tested, solvent-free production
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — 1,500mg THCa as separate ingredient
Delta-9 THC exposure	600-900mg/day at peak	90mg total in entire 30mL bottle (3mg/mL)
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted with 29 peer-reviewed citations

Why OilWell’s formulas diverge from traditional RSO

Multi-cannabinoid approach. Traditional RSO relied on whatever single strain the maker grew. OilWell’s formulas intentionally include seven cannabinoids because the entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29].

Terpene preservation. Traditional RSO had essentially no terpene content. OilWell includes live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible and supported at the preclinical level [20]-[28].

THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. OilWell’s sublingual formula includes THCa at 1,500mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12].

Reduced delta-9 THC dominance. Traditional RSO was 60-90% delta-9 THC. OilWell’s formula uses delta-9 THC at only 90mg total, distributing the remaining cannabinoid content across CBD, CBG, delta-8 THC, CBN, and CBC.

Product format innovation. Simpson envisioned only one format: an oral oil. OilWell offers both a 30mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulations acknowledging that different delivery routes have different pharmacokinetic profiles [14].

Solvent safety and extraction evolution

Traditional RSO production used naphtha or isopropyl alcohol — neither food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete solvent purging leaves potentially harmful residues.

Modern extraction uses food-grade ethanol or supercritical CO₂, allowing for much more complete solvent removal. Finished products can be tested for residual solvents using validated analytical methods. This is one of the most straightforward safety improvements over traditional RSO.

The decarboxylation question

Traditional RSO was fully decarboxylated. The heat involved in solvent evaporation converted essentially all THCa into delta-9 THC, leaving patients with no choice about psychoactivity.

OilWell’s sublingual formula deliberately preserves THCa at 1,500mg as a separate ingredient. This creates three distinct usage options:

Option 1 — Raw, no heat. All 1,500mg stays as THCa — completely non-psychoactive. Compatible with work, driving, and daytime use with zero impairment. Perfect for Cleveland County residents who need to operate equipment, drive the back roads to Pine Bluff, or stay clear-headed for family responsibilities.

Option 2 — Fully activated, home decarboxylation. Heating the oil at 260°F (125°C) for 45 to 60 minutes converts 1,500mg THCa into approximately 1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, this yields approximately 1,405mg total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

Option 3 — Vape, auto-decarboxylation. The RSO Vape Cartridge vaporizes at 400 to 450°F, instantly converting THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids.

The conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1mg THCa = 0.877mg delta-9 THC after decarboxylation.

This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing it through actual product chemistry.

Terpene loss in traditional RSO

Terpenes are volatile aromatic compounds with relatively low boiling points. Most cannabis terpenes begin to volatilize at temperatures between 21°C and 157°C. The traditional RSO production process destroyed terpenes through solvent extraction and high-heat evaporation.

OilWell’s formulas specify live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each terpene has its own evidence profile discussed below. The entourage-effect literature provides the theoretical framework for why preserving terpenes alongside cannabinoids may matter pharmacologically [20][29].

Evidence standards then and now

Rick Simpson operated in a pre-legalization, pre-lab-testing era. His evidence was anecdotal. His production was unstandardized. His claims were untested in any formal sense.

This document takes a fundamentally different approach. We apply a formal evidence hierarchy: human clinical evidence first, then systematic reviews, then institutional summaries, then preclinical literature [1]-[29]. Every compound-level claim is tied to specific peer-reviewed sources with evidence strength clearly labeled.

Where Simpson relied on personal testimony, this document relies on published literature and institutional sources. We honor the historical origin of RSO while committing to the standards of modern cannabinoid science.

Simpson’s protocol vs. modern dosing considerations

Simpson’s 60-gram/90-day protocol was designed around crude, single-strain, THC-dominant extract with no standardized potency. OilWell’s products are fundamentally different:

• Cannabinoid concentration: OilWell’s sublingual formula delivers 553mg of total active cannabinoids per mL across seven defined compounds. Traditional RSO potency was unknown and variable.
• Cannabinoid ratios: Simpson’s oil was approximately 60-90% delta-9 THC. OilWell’s formula distributes 16,590mg across CBD (4,500mg), CBG (3,000mg), delta-8 THC (6,000mg), THCa (1,500mg), delta-9 THC (90mg), CBN (750mg), and CBC (750mg).
• Terpene presence: Simpson’s oil had no terpenes. OilWell’s formula includes live terpenes at 5%.
• Delta-9 THC exposure: Simpson’s protocol delivered approximately 600-900mg of delta-9 THC per day. OilWell’s sublingual formula contains only 90mg of delta-9 THC in the entire 30mL bottle (3mg per mL).

Cleveland County residents should not follow Simpson’s dosing protocol with OilWell products. Our formulas require their own dosing approach, informed by the per-compound evidence in this document and responsible titration principles.

References for this section

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024.

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

The origin of OilWell Cannabis

We were founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. A lot of his best friends have been killed or are in prison because of the associated dangers. He has faced every form of violence imaginable. By sixteen, one way or another, he had to leave home for good.

Despite the dangers, Colin did not fall into the darkest paths. Instead, he focused on cannabis, seeing it as a safer and more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines our approach.

The company’s origin story begins with a dog named Bentley. Bentley was more than just a pet — he was family. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said the pain medications would destroy his internal organs.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Determined to save Bentley, Colin created CBD golden paste — a specialized cannabinoid formula for pets. That hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. Dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed formulas for every age-related condition Bentley faced. Neurodegeneration led him to CBG’s neuroprotective properties and THCa’s PPARγ agonism. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Minor cannabinoids like CBG, CBN, and CBC became critical. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Cleveland County pet owners understand this story. Whether you’re in Rison with an aging lab who can’t climb into the truck anymore, or in New Edinburg with a cat suffering from arthritis, you know the desperation of watching a beloved companion decline and being told there’s nothing left to try. The golden paste recipe that saved Bentley is published at the end of this guide — free for any Cleveland County resident to make for their own animals.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey using the cannabinoid knowledge he developed keeping Bentley alive. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, we also offer Peace Gummies in vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live.

Over time, the therapeutic benefits of cannabis became the core of our work. We’ve developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. Our focus has always been on making cannabis accessible for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 Houston — seven features spanning four years

Between September 2019 and April 2023, ABC13 KTRK Houston featured Colin and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

Why this matters for Cleveland County residents: When Houston’s number-one news source needed to explain cannabis products, legal changes, or community health initiatives, they called us. This mainstream media validation from a major-market ABC affiliate establishes a credibility that no amount of marketing could replicate. When you’re ordering a product online to ship to Rison or New Edinburg, you need to know you’re dealing with a real, verified company — not a fly-by-night operation.

Our most foundational quote, from September 2019, captures our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That was our position before we ever published a formula, and it’s our position today.

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. All artwork, formulations, and packaging are created in-house in Houston, using only our own recipes and ideas.

The OilWell RSO philosophy

Our RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but deliberately different in ways that solve problems.

1. Accessibility over gatekeeping. No medical card is required. Anyone age 21 or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. For Cleveland County residents, this is crucial: Arkansas has a medical marijuana program, but there are no dispensaries in Cleveland County. The nearest options are in Pine Bluff (Jefferson County) or Little Rock — both over an hour’s drive. Our direct-to-consumer model eliminates that barrier.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Whether you’re a farmer in Kingsland who needs to stay sharp operating equipment, or a retiree in Rison who wants full-strength relief at night, you control the experience.

3. Open-source formulas. We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford our products can source ingredients and make their own version. We’ll publish the exact recipe later in this guide. This is a direct echo of Rick Simpson’s original ethos: he gave his oil away for free; we sell a professional product and publish the recipe.

4. Evidence-informed, not evidence-overstating. The GENERAL KNOWLEDGE section of this document represents our commitment to honest education about what the science actually says. We distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill compliance and the THCa legal framework for Cleveland County

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30mL bottle — 3 milligrams per milliliter — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Arkansas.

For Cleveland County residents specifically: Arkansas law aligns with the Farm Bill. Hemp-derived products with less than 0.3% delta-9 THC are legal to purchase, possess, and use. You do not need a medical marijuana card. You must be 21 or older.

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC. But here’s the crucial part: you can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container.

This converts 1,500mg of THCa into approximately 1,315mg of delta-9 THC. Combined with the existing 90mg delta-9 THC in the formula, this produces approximately 1,405mg total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

Important legal notice for Cleveland County customers: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Arkansas law. We ship with full documentation, Certificates of Analysis, and receipts. The product is legal as shipped; what you do with it after delivery is your responsibility under Arkansas law.

Open-source formulas — why we publish everything

We publish our complete RSO formulas publicly — every cannabinoid, every milligram amount, every percentage — right here in this document. If you cannot afford our products ($129.99 for sublingual oil, $49.99 for vape cartridge), you can see exactly what the formula contains, source the individual cannabinoid distillates and isolates, and make your own version.

This is a direct echo of Rick Simpson’s original ethos. He gave his oil away for free and taught people how to make it. He never patented his method. We adapted that ethos for the modern marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

CBD golden paste recipe for pets — the original open-source formula

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size and needs; consult a veterinarian)

Instructions:

1. Mix turmeric and water in a saucepan over low heat, stirring continuously until it forms a thick paste (7-10 minutes). Add more water if needed.
2. Add coconut oil and freshly ground black pepper. Stir until thoroughly mixed.
3. Allow to cool, then transfer to a jar with lid. Store in refrigerator for up to two weeks.
4. Add CBD oil to paste before giving to pet, adjusting dosage based on weight and health needs.

Serving suggestion: Mix a small amount with pet’s food once or twice daily. Monitor for changes and consult a veterinarian if concerns arise.

This recipe — published for free, years before our RSO formulas were open-sourced — demonstrates that the pattern is consistent. We gave away the formula that saved Bentley before we gave away the formula for people. The open-source ethos is not a marketing strategy; it is our foundational behavior.

The decarboxylation choice — patient-controlled potency

Traditional RSO was always fully decarboxylated. Our sublingual formula contains 1,500mg of THCa in its acidic, non-psychoactive form, creating three distinct usage options:

Option 1 — Raw, no heat. All 1,500mg stays as THCa — completely non-psychoactive. Perfect for daytime functional use in Cleveland County.

Option 2 — Fully activated, home decarboxylation. Heat at 260°F for 45-60 minutes converts 1,500mg THCa to ~1,315mg delta-9 THC, yielding ~1,405mg total delta-9 THC. You can decarboxylate the entire bottle or just a portion in a separate container, preserving the rest raw.

Option 3 — Vape, auto-decarboxylation. The RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. Fastest-onset RSO delivery available.

This design puts the potency decision entirely in your hands — whether you’re a Cleveland County teacher who needs to stay sharp during the day or a retiree seeking full-strength relief at night.

Solvent-free production

Our RSO is not a traditional extraction product. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents.

We use organic MCT oil as the carrier base — a food-grade lipid that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile. This is a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers:

• Cannabinoid potency (HPLC/UHPLC analysis, ±2% accuracy)
• Terpene profile
• Pesticides (400+ compound screening)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis are available on request and accessible through our website. For Cleveland County residents ordering online, this testing documentation ships with every package.

The broader OilWell product portfolio

Beyond RSO, we produce a range of cannabinoid products, each developed from the formulation knowledge Colin built over Bentley’s ten-year journey:

Asshole Peach — Our most popular product. Peach gummy rings with 268mg total cannabinoids per piece (28mg delta-9 THC, 50mg delta-8 THC, 20mg delta-10 THC, 20mg THCo, 100mg CBD, 50mg CBG). Particularly favored by veterans for PTSD and pain relief.

Peace Gummies — Developed directly from Colin’s own experience with PTSD and benzodiazepine addiction. Each peach contains 320mg total cannabinoids (30mg CBN, 15mg delta-9 THC, 25mg delta-8 THC, 100mg CBD, 150mg CBG). The formula that helped him quit Xanax cold turkey.

SWEETEMintz — Sugar-free vegan peppermint hard candy with 28mg delta-9 Nano THC, 100mg Nano CBD, 50mg CBG Isolate. Zero sugar, 100% vegan — designed for diabetic and health-conscious consumers.

Custom creations — We offer custom-made products tailored to individual needs. Whether specific cannabinoid ratios, particular delivery formats, or formulations for unique health circumstances, we design targeted products on request. This includes formulations for vegans, diabetics, and those with specific dietary needs.

Two product formats

We offer the RSO formula in two delivery formats, each designed for different use cases:

RSO Sublingual Oil — $129.99

• 30mL bottle (1 fl oz)
• 16,590mg total cannabinoids (553mg per mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper for precise dosing in 0.1mL increments
• Onset: 15-45 minutes
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Approximately 40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900mg+ total cannabinoids
• Same six-cannabinoid ratio (no separate delta-9 THC listed — THCa auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest cannabinoid delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

Complete RSO Guide: OilWell.com/rso-guide

When to use each format

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability and discretion	Vape	Compact, no measuring
Precise dosing control	Sublingual	Graduated dropper (0.1mL increments)
Daytime non-psychoactive use	Sublingual (raw)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

Competitive comparison — OilWell RSO vs. alternatives

What Cleveland County residents are likely to encounter:

Option 1: Drive to a medical dispensary in Pine Bluff or Little Rock

• Requires Arkansas medical marijuana card ($50 application, qualifying condition needed)
• Nearest dispensary: ~1.5 hours from Rison
• Products are THC-dominant, limited cannabinoid diversity
• No same-day access

Option 2: Order from national CBD brands

• Typically 1,000mg total cannabinoids per bottle vs. our 16,590mg
• No psychoactive option (no THCa or delta-8 THC)
• Often single-cannabinoid (CBD only)

Option 3: DIY extraction at home

• Extremely dangerous: naphtha/isopropyl alcohol are flammable and toxic
• Fire risk especially high in Cleveland County’s rural homes
• No testing for contaminants
• Inconsistent potency

Option 4: OilWell Cannabis

• Ships directly to Cleveland County, Arkansas
• No medical card required (Farm Bill compliant)
• 7 cannabinoids, 7 terpenes, lab-tested
• Patient-controlled potency (raw or decarbed)
• $129.99 for 30mL (16,590mg) — far more cost-effective per milligram

Condition-specific usage context

Important disclaimer: These usage contexts are informed by cannabinoid research cited in the GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. Always consult a qualified healthcare provider before using cannabinoid products. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-related nausea and appetite support (for patients traveling to UAMS or other cancer centers)

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)

Chronic pain (fibromyalgia, arthritis, neuropathy from years of physical labor)

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory without psychoactive impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Sleep support

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL, delivers 50mg CBN — the dosage level investigated in 2024 sleep literature
• At 1.0mL, delivers 25mg CBN — above the 20mg threshold associated with reduced sleep disturbance

Anxiety and stress (PTSD, especially among Cleveland County veterans)

• Daytime functional relief: 0.3mL raw sublingual — CBD and CBG address anxiety without impairment
• Nighttime: 1.0mL sublingual — full cannabinoid profile including CBN for sleep architecture

General titration principle: Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and global accessibility for Cleveland County

Houston same-day delivery zones (for reference on our local operations):

• Texas Medical Center: FREE (2-4 hours)
• Inner Loop (610): $5 (2-4 hours)
• Within Beltway 8: $10 (3-5 hours)
• Greater Houston suburbs: $15 (4-6 hours)
• Extended region (60 miles): $20-25

Nationwide shipping to Cleveland County, Arkansas:

• Ships to all 50 states where Farm Bill products are legal
• USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding
• Tracking provided for all orders
• Temperature-stable packaging for Arkansas summers
• Signature-required option available

International shipping:

• Ships to multiple countries across continents
• Includes full documentation, Certificates of Analysis, receipts for customs
• Minimum flat-fee shipping; excessive costs billed to customer
• Customer responsible for verifying legality in their jurisdiction

For Cleveland County specifically: We ship directly to your address in Rison, Kingsland, New Edinburg, or anywhere in the county. No need to drive to Pine Bluff or Little Rock. No medical card required. Order online and receive within 2-3 business days via USPS Priority Mail.

Our PANDEM1C SEO technology — with 14 million distinct geopolitical locations in its database and over 300 AI models — drives organic search visibility, making our products discoverable to patients in Cleveland County searching for RSO in their own language and context.

How the OilWell formulas connect to the evidence

Every cannabinoid in our formula — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — has its own evidence profile in the GENERAL KNOWLEDGE section. Every terpene — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — is covered with preclinical and review-level evidence.

Our formulas are anchored to per-compound evidence summaries. We do not exempt ourselves from the same evidence standards applied to the broader field. Where we make specific research claims about individual cannabinoids or terpenes, this document provides the source evaluation context — the same peer-reviewed citations, the same evidence-tier assessments, and the same cautious interpretation framework.

OilWell is more than a brand — it is a commitment to integrity, creativity, and the mission that started when Bentley got up, walked across the room, and brought his ball to play. For Cleveland County residents seeking honest RSO education, we offer both the products and the knowledge to make informed decisions.

MEDIA RECOGNITION AND COMMUNITY IMPACT

Colin Valencia — Houston’s go-to cannabis authority

Between September 2019 and April 2023, ABC13 Houston featured Colin and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different reporters sought us out across those years. No other Houston cannabis operator appears with that frequency or breadth.

What this means for Cleveland County: When you order from OilWell, you’re choosing a company that major media has repeatedly verified as credible, knowledgeable, and community-focused. These features cannot be purchased — they can only be earned.

Complete feature chronology

September 15, 2019 — CBD Business Boom
Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

March 22, 2021 — Decriminalization Efforts
Colin’s therapy quote: “Pain comes in a lot of different forms.”

May 24, 2021 — Delta-8 THC “Legal Weed”
Iconic exchange with Steve Campion: “Maybe you want to get high.” Radical honesty on mainstream television.

August 20, 2021 — COVID Vaccine Giveaway
We gave away approximately $35,000 in product (1,000 caviar pre-rolls) to encourage vaccination, coordinating with the city of Houston. No political strings attached.

October 19, 2021 — Delta-8 Ban
Colin proactively removed all Delta-8 products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics. Ethical leadership during a regulatory crisis.

October 7, 2022 — Biden Marijuana Pardon
Revealed Colin’s personal marijuana conviction history. Transformative context showing we speak from lived experience, not just business interest.

April 21, 2023 — Texas Marijuana Laws
“Renaissance” framing: “Right now is actually a pretty important time that should be enjoyed now.”

The through-line — what the media record reveals

Consistency across years. ABC13 returned to us across four years of dramatic industry changes.

Breadth of expertise. We were asked to speak to business, law, medicine, community health, and politics.

Community action. The COVID vaccine giveaway ($35,000 in product) and proactive Delta-8 removal demonstrate community-first philosophy.

Personal stakes. Colin’s cannabis conviction history transforms every quote into lived experience, not corporate talking points.

Evolution of language. From “local wholesaler” (2019) to industry authority (2023), the media record tracks authentic growth.

For Cleveland County residents evaluating who to trust with your health and money, this media record is independently verified credibility — not our marketing, but ABC13’s editorial judgment, repeated over four years.

GENERAL KNOWLEDGE

Research method and evidence weighting

This section prioritizes sources in order: human clinical evidence, systematic reviews, NIH/institutional summaries, then preclinical literature when human data are sparse. The evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and in vitro pharmacology [1]-[29].

Institutional baseline from NIH

• NCCIH states the strongest established cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea/vomiting, and HIV/AIDS appetite issues. Modest evidence exists for chronic pain and MS symptoms. Many claimed uses remain uncertain [1].
• FDA has not approved the cannabis plant itself for medical use, though purified CBD and synthetic THC analogues have specific approvals [1].
• Safety concerns include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, and THC-vape lung injury [1].
• NCCIH warns that over-the-counter CBD products may differ from labels and cause decreased alertness, GI effects, liver abnormalities, and drug interactions [1].

Cannabinoid evidence profiles

CBD [1]-[6]

• Strongest evidence: seizure disorders (Epidiolex)
• Anxiety: 2024 systematic review shows anxiolytic signal but limited clinical sample [3]
• Pain: 2024 review promising but heterogeneous [4]
• Sleep: 2023 review methodologically weak [5]
• Safety: 2023 review shows liver enzyme elevation risk, especially with concentrated oral products and polypharmacy [6]

CBG [7][8]

• Mostly review-level and preclinical; human evidence sparse
• Pharmacology: cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling [7]
• Potential areas: neurologic disorders, IBD, antibacterial activity [7][8]
• Commercially sold while evidence base remains thin; claims outrun science [7]

Delta-8 THC [9]-[11]

• Pharmacologically relevant, psychoactive, less clinically characterized than delta-9 THC
• 2022 review: similar PK/PD to delta-9 THC but less potent, weaker CB1 affinity [9]
• 2023 scoping review: dominated by animal studies, product chemistry, use reports, public health concerns; adverse consequences reported [10]
• Manufacturing concerns: greater stability and easier synthesis than natural plant levels; product byproduct and lab-testing questions [11]
• Bottom line: psychoactive THC analogue with real activity but incomplete human safety characterization [9]-[11]

THCa [12]

• Acidic precursor to THC; may represent large share of THC-related content in raw plant
• Does not produce psychoactive effects if stays acidic, but converts to THC during heating/storage [12]
• In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities, but not established human outcomes [12]
• Bottom line: highly relevant precursor whose interpretation depends on route, temperature, processing, storage [12]

Delta-9 THC [1][13]-[15]

• Strongest human evidence of psychoactive cannabinoids, but clearest adverse-effect burden
• NCCIH: relevant to chemo nausea, HIV appetite, some MS/pain outcomes [1]
• 2022 systematic review: high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, discontinuation [13]
• PK: inhaled onset seconds-minutes, peaks 15-30 minutes; oral onset later, peaks later, longer duration [14]
• 2025 review: high-concentration THC products consistently associated with psychosis/schizophrenia, CUD, anxiety/depression signals [15]
• Bottom line: legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15]

CBN [12][16][17]

• Marketed for sleep, but clinical support far weaker than marketing suggests
• 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography [16]
• 2024 sleep review: cannabinoid sleep research doesn’t match real-world use scale; need for better-designed trials [17]
• Bottom line: cultural reputation stronger than current clinical evidence [16][17]

CBC [18][19]

• Emerging, intriguing, overwhelmingly preclinical/review-based
• 2024 review: distinct pharmacodynamics, antinociceptive, antibacterial, anti-seizure potential [18]
• Over-the-counter products sold despite little evidence establishing clinical efficacy or safety [18]
• Bottom line: scientifically credible minor cannabinoid deserving more research, not clinically validated [18][19]

Terpene evidence profiles

Limonene [20]-[22]

• Review and preclinical evidence; multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immunomodulatory possibilities [21]
• Safety: limonene oxidation products (hydroperoxides) are clinically relevant contact allergens [22]
• Bottom line: biologically active but cannabis-specific therapeutic claims should stay conservative [20]-[22]

Myrcene [20][23]

• Mostly preclinical; anxiolytic, antioxidant, anti-inflammatory, analgesic properties discussed, but human studies lacking [23]
• Consumer language often stronger than evidence (e.g., “proven sedative,” “explains couch-lock”) [20][23]
• Bottom line: plausible bioactive terpene, but clinical claims remain far ahead of proof [23]

Caryophyllene [20][24]

• Mechanistically interesting: selective CB2 receptor agonist, unusual for a terpene [24]
• Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective potential [24]
• Bottom line: strongest candidate for terpene with cannabinoid-system significance, but not clinically proven [24]

Pinene [20][25]

• Promising preclinical literature; 2021 brain-health review found antioxidant, anti-inflammatory, neuroprotective signals [25]
• Claims about memory improvement, attention sharpening, counteracting THC cognitive effects remain hypotheses [20][25]
• Bottom line: deserves scientific attention, but strong cognition claims are exploratory [25]

Linalool [20][22][25][26]

• Substantial preclinical interest; stress, mood, brain-health pharmacology [25][26]
• Oxidized linalool hydroperoxides recognized allergens [22]
• Bottom line: scientifically credible but therapeutic promises should be cautious [22][25][26]

Humulene [20][27]

• 2024 scoping review of 340 articles: broad preclinical evidence for anti-inflammatory effects, some rodent work suggesting cannabimimetic properties [27]
• Bottom line: interesting research target, far from clinically settled [27]

Terpinolene [20][28]

• Least clinically characterized in this list; 2021 systematic review screened 2,449 records, included 57 studies, concluded evidence dominated by in silico, in vitro, animal studies [28]
• Bottom line: biologically interesting but especially underdeveloped clinically [20][28]

Research limits and interpretation

• Evidence base is highly uneven; CBD and delta-9 THC support most detailed statements; others require more caution [1]-[29]
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable
• Minor cannabinoids and terpenes are commercially interesting because underexplored, but claims often inflated
• Product quality matters as much as molecule identity: labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent PK all affect real-world interpretation [1][10][11][14]
• For THCa, chemistry is destiny: storage and heating can change exposure profile by converting acidic to neutral cannabinoids [12]

Common overstatements to avoid

Overstatement → More accurate

• CBN is a clinically proven sleep cannabinoid → The specific sleep evidence for CBN remains weak, with no strong validated-trial base yet identified [16][17]
• Myrcene is a proven human sedative → Myrcene has plausible preclinical bioactivity, but direct human proof for that claim is limited [20][23]
• Terpenes have proven entourage effects → Entourage hypotheses are influential, but robust clinical proof remains limited [20][29]
• THCa is always nonpsychoactive → THCa itself is not THC, but heating can convert THCa to THC, changing exposure [12]
• Delta-8 THC is safe because hemp-derived → Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, with manufacturing/testing concerns [9]-[11]

Practical takeaways for the formulas in this document

• Most evidence-developed actives: CBD and delta-9 THC
• Delta-8 THC is not trivial; it’s psychoactive with less robust safety/efficacy characterization than delta-9 THC
• THCa meaningfully changes with processing
• CBG, CBN, CBC are scientifically credible but clinically immature
• Terpene claims should be careful; compound-specific human therapeutic claims only where directly supported

RSO SUBLINGUAL OIL FORMULA

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg
• Carrier: Organic MCT oil
• Price: $129.99

For Cleveland County residents making your own: This table is your recipe. Source individual cannabinoid distillates and isolates, mix in these exact proportions with organic MCT oil and live terpenes at 5%. The open-source nature means you’re not locked into our price point if you have the means and knowledge to compound it yourself.

RSO VAPE CARTRIDGE FORMULA

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Compatibility: 510-thread universal battery
• Price: $49.99

Note for Cleveland County vape users: THCa auto-decarboxylates at vaping temperature (400-450°F), converting to delta-9 THC with each puff. Every inhalation delivers freshly activated cannabinoids. This is the fastest RSO delivery method available.

TERPENE PROFILE (Both Products)

• Limonene — citrus-bright
• Myrcene — earthy, musky
• Caryophyllene (β-caryophyllene) — pepper/spice
• Pinene — forest-fresh
• Linalool — floral, lavender
• Humulene — earthy, woody
• Terpinolene — piney, fruity, sparkling

These terpenes are preserved live at 5% concentration, not destroyed by heat like in traditional RSO. For Cleveland County residents familiar with local flora — the pine forests around Millwood Lake, the citrus groves in southern Arkansas, the peppery scent of summer fields — these aromatic compounds connect to familiar scents while providing potential pharmacological benefits through the entourage effect [20][29].

FINAL WORDS FOR CLEVELAND COUNTY

We’ve built OilWell Cannabis on a simple promise: to provide the most thoughtful, evidence-informed cannabis products available, with the transparency and accessibility that Cleveland County residents deserve. Whether you’re managing chronic pain from decades of physical work, supporting a loved one through cancer treatment in Little Rock, or seeking alternatives to pharmaceuticals that haven’t served you well, we offer both the products and the knowledge to make informed decisions.

Our products ship directly to Rison, Kingsland, New Edinburg, and every corner of Cleveland County. No medical card required. No driving to Pine Bluff. Just honest products, published formulas, and the same ABC13-verified credibility we’ve maintained since 2019.

If you’re ready to explore what our RSO formulas might do for you, visit OilWell.com/rso or call (832) 416-2816. Our Houston team is available Monday-Thursday 10am-7pm, Friday-Saturday 10am-10pm, Sunday 10am-4pm Central Time.

And if $129.99 isn’t in your budget right now? The recipe is right here. Make it yourself. That’s exactly what Rick Simpson would have wanted, and it’s exactly what we want for you.

Stay safe, stay informed, and take control of your own medicine.

Business Hours:
Monday-Thursday: 10:00 AM – 7:00 PM
Friday-Saturday: 10:00 AM – 10:00 PM
Sunday: 10:00 AM – 4:00 PM

Contact:
Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/
Instagram: @oilwellcbd
Address: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

Legal Notice:
These products have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before use. Must be 21+ to purchase. Buyer responsible for verifying local Arkansas laws. Keep out of reach of children. May cause drowsiness. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Use only as directed. Individual results may vary.

For Cleveland County Residents: Arkansas law permits hemp-derived products with <0.3% delta-9 THC. This product complies. THCa converts to delta-9 THC when heated; you are responsible for compliance with Arkansas law regarding decarboxylation and possession of converted material.